Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24neg cells in the locally advanced and metastatic breast cancer

Documenti analoghi

• Expression of CD44highCD24Low cells, SOX2, and STAT3 transcription factors on peripheral blood and tumor tissue of penile squamous cell carcinoma
  di: Felipe Dubourcq de Barros, et al.
  Pubblicazione: (2024)
• Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer
  di: Marcelo Ramos Tejo Salgado, et al.
  Pubblicazione: (2024)
• Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy
  di: Carolina de Souza Vasconcelos, et al.
  Pubblicazione: (2025)
• Circulating levels of galectin‐9 are a potential biomarker of survival in advanced non‐small‐cell lung cancer
  di: Guilherme Vieira de Mendonça Filho, et al.
  Pubblicazione: (2024)
• Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma
  di: Cecilia Araújo Carneiro Lima, et al.
  Pubblicazione: (2024)